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The ethno-racial basis of chronic 
diseases: Rethinking race 
and ethnicity from a critical 
epidemiological perspective
Melania Calestani and Laura Montesi
An engaging five-day workshop on critical medical anthropology organ-
ised by CIESAS and UCL was coming to an end. It was a sunny Friday in 
January and the Central Valleys of Oaxaca promised a spectacle of beauty 
and historical heritage to a group of anthropologists. We were about to 
visit Monte Albán, an archaeological site, testament to the Zapotec civ-
ilisation and its power over the region. We were still riding the wave of 
the workshop debates when we met our tourist guide. We introduced 
ourselves to him and when Laura said that she worked with diabetes 
patients, the guide observed that diabetes is the largest epidemic in Mex-
ico, caused by an unhealthy food system and by wrong eating behaviours 
triggering defective genes: ‘We, Mexicans, are genetically predisposed to 
diabetes.’
We looked at each other and immediately understood that we 
were thinking along the same lines. We had been talking about racial-
ised societies and health during the last few days, having found paral-
lels between our respective works on social representations of diabetes 
in Mexico, and on chronic kidney disease and kidney transplant listing 
in the UK. We were wondering about the growing explanatory power of 
genetic aetiologies in health discourses and about how and why certain 
social groups, often detected on the basis of ethno-racial differences, end 
up being described by researchers, physicians and public health workers 
as genetically prone to many diseases and conditions, including type 2 
diabetes (hereafter diabetes) and chronic kidney disease. We had also 
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discussed the ways in which such representations and medical and sci-
entific practices become part of the public imaginary, intersecting with 
popular notions of race, ethnicity, fitness and weakness.
In the 1990s, Lippman introduced the term ‘geneticisation’ to 
describe ‘an ongoing process by which differences between individuals 
are reduced to their DNA codes, with most disorders, behaviours and 
physiological variations defined, at least in part, as genetic in origin. It 
refers as well to the process by which interventions employing genetic 
technologies are adopted to manage problems of health’ (1991: 19).
The term geneticisation is resonant with ‘medicalisation’, which 
indicates processes ‘by which nonmedical problems become defined 
and treated as medical problems, usually in terms of illnesses and disor-
ders’ (Conrad 1992: 209). Although medicalisation can have beneficial 
impacts, it has traditionally been seen with suspicion by medical anthro-
pologists in light of the tendency by societies to label deviance and use 
medicine as a means of control, punishment or marginalisation. Finkler 
(2000) expressed concern about the mushrooming growth of beliefs in 
genetic inheritance because they are instrumental to the individualis-
ation of health problems and the technification of solutions. Kinship and 
ethno-racial genetic explanations and solutions sit easily within the cur-
rent global neoliberal climate and the growing ‘economisation’ of ‘here-
tofore noneconomic spheres and activities’ (Brown 2015: 17). As Marks 
(2013) highlights, genetic and genomic research projects usually prom-
ise solutions, mainly diagnostic tools, which are easily privatised (2013: 
257). This raises more than one question about the interests behind sci-
entific research, an issue that is becoming of paramount relevance as 
public funds diminish and corporations are increasingly being subsidised 
by state governments to promote research and provide health services 
(Clarke et al. 2003: 167).
To disentangle how political and economic forces shape scientific 
research and medical practice, we draw on Breilh’s critical epidemiology 
(CE), which serves a double purpose: it supersedes the limits of con-
ventional epidemiology with its multi-causal (yet still lineal) model of 
disease and rethinks ‘health as a complex, multidimensional object, sub-
mitted to a dialectical process of determination’ (Breilh 2008: 747). By 
dissecting two case studies, social representations of diabetes in Mexico 
and ethnic minorities in transplant medicine in the UK, we analyse how 
science, considered in its broadest sense (as it is practised and communi-
cated), reinvents race and ethnicity and can inadvertently contribute to 
deepening racialised inequalities in stratified societies. We examine how 
this over-emphasis on ethno-racial genetic aetiologies in chronic diseases 
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diverts attention and resources from more important influences on pop-
ulations’ health, such as embedded health inequalities exacerbated by 
colonial pasts, neoliberal capitalism and institutionalised racism. In line 
with recent discussions in the anthropology of epigenetics (Lock 2013; 
Thayer and Non 2015), we draw on Kuzawa and Sweet’s work to suggest 
how ‘social influences can become embodied, having durable and even 
transgenerational influences’ (2009: 2). Ethno-racial differences in dis-
ease patterns are then embedded in pathways of power, characterised by 
a somatisation of racial tensions (Guthman 2014) that profoundly affects 
local biologies (Lock and Nguyen 2010). We argue that CE permits us to 
move some of these discussions forward in specific ways: for instance, 
identifying how biologies are moulded within their larger ecological con-
texts, or webs of relationships, and how social systems, ways of life and 
health are inextricably linked.
Ethno-racial discourses and health
Concepts of race and ethnicity are among the most controversial and 
contentious classifications in our social and scientific landscapes. In 
health research, genotypes have often been associated with ethnic/cul-
tural identity, showing poor consistency in terminology and reinforcing 
ethno-racial stereotypes (Sheldon and Parker 1992). Race and ethnicity 
have then become mere statistical categories, denying the complex inter-
actions among political-economic processes, lived experiences, societal 
ways of living and human biologies (Goodman 2000; Krieger 2001).
In this chapter, rather than engaging with race as a physical or phe-
notypical category, we draw on Gilroy’s and Ahmad’s understandings of 
racialisation. The former talks about it as the existence and hegemony 
of ‘raciological’ thinking that affects the world and provides differential 
access to resources for members of different groups (Gilroy 2005: 39), 
while the latter conceptualises it as a process that ‘assumes that “race” is 
the primary, natural, and neutral means of categorization, and that the 
groups are distinct also in behavioural characteristics, which result from 
their race’ (Ahmad 1993: 18).
We argue that race and ethnicity are polysemic terms, acquiring a 
plurality of meanings according to the (inter)national and local circum-
stances in which they are employed. Moreover, their use responds to ide-
ological and political propositions grounded in power unbalances. The 
rise of the race concept in the fifteenth century as part of the European 
conquest and as a means of legitimisation (Smedley 1998; Ahmad and 
Bradby 2007) reveals its political and colonial genesis. Historically, the 
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involvement of health within racial representations has been instrumen-
tal, not incidental (Keval 2016). Arguments on health and hygiene were 
(and still are) racially coded and have been central to (post-)colonial 
practices of inclusion and exclusion (Mawani 2003; Shah 2001; Gilman 
1988). Nineteenth-century health and hygiene movements were con-
cerned with maintaining the boundaries between populations.1
In tandem with biological depictions of race, ethno-racial dif-
ferences in health have also been explained in terms of cultural inade-
quacies, mobilising essentialised notions of ‘culture’ (Ahmad 1993). 
According to Menéndez (2001), since the 1950s, we have witnessed an 
expansion of biological understandings of everyday life and the rise of 
the concept of lifestyle as a signifier for (un)healthy behaviour, working 
as a mechanism of differentiation, stigmatisation and subalternisation. 
Likewise, in health research, racial and ethnic-group comparisons of 
health indices frequently are presented without stratifying or adjusting 
for socio-economic conditions that could affect the interpretation of the 
data (Lillie-Blanton and Laveist 1996).
CE provides a criticism of dominant biomedical and epidemiologi-
cal explanations of health and illness, unveiling their reductive biologi-
cal orientation and shedding light on how large-scale political economic 
processes ‘get under the skin’ (Leatherman and Goodman 2011): for 
instance, how racism and chronic stress affect local biologies through 
processes of somatisation (Kuzawa and Sweet 2009) or how the ever- 
growing reproduction of capital under market rules reduces the spaces 
‘for the fulfilment of life and health’ (Breilh 2008: 747).
Amerindian genes and the Mexican susceptibility to diabetes
Diabetes in Mexico has become a top health, social and economic con-
cern. Its prevalence rate ranges between 9.2 and 14 per cent, making it 
one of the highest worldwide (world prevalence in 2014 was 8.5 per cent 
of adults aged 18 and older (WHO 2016)) and the highest among Organ-
isation for Economic Cooperation and Development (OECD) member 
countries (OECD 2015). In only 30 years (1980–2010) diabetes has gone 
from being the ninth to the second cause of death in the Mexican general 
population (Secretaría de Salud 2012: 38). People with diabetes often 
have to endure suffering and pain due to severe disability. According 
to a recent report (Secretaría de Salud 2015: 20), in 2013, 30 million 
 disability-adjusted life years were lost, especially among two age groups, 
adults between 35 and 60 years of age and the over-80s. The statistics are 
indisputable. What is questionable is how this epidemiological panorama 
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is portrayed and addressed by a number of institutional actors, from state 
representatives and public health workers to researchers and journalists.
State representatives say the diabetes epidemic is a national threat. 
The Mexican ex-Minister of Health, Mercedes Juan, described diabetes 
as a ‘health emergency […] capable of jeopardising [Mexico’s] viabil-
ity as a nation’ (Secretaría de Salud 2013: 7). In 2013, President Peña 
Nieto launched the National Strategy for the Prevention and Control 
of Overweight, Obesity and Diabetes, designed to promote behavioural 
changes, increase epidemiological surveillance, make health services 
more accessible and regulate the sale of high-calorie food and bever-
age products. The strategy, contained in a 105-page document, showed 
a limited understanding of the role that social inequalities play in dis-
ease distribution. While launching his national strategy, President Peña 
expressed the need for citizens to be ‘informed, active and healthy’ and 
lamented the fact that the Mexican population ‘suffers from overweight 
problems and lacks healthy habits’. He exhorted people to interrupt their 
sitting time with at least one hour of exercise per day (Presidencia de 
la República 2013). Discourses like these tend to frame diabetes not 
only as a Mexican problem but also as one that reflects Mexicanness, 
constructed around stereotypes of laziness, a propensity to over-eat and 
focus on the present, and the lack of a culture of prevention. In con-
junction with behavioural/cultural explanations, the diabetes epidemic 
is also narrated in terms of ethno-racial predisposition, due to genetic 
variations that are ‘exclusive of mestizo populations, whose Amerindian 
component is under study’ (Secretaría de Salud 2013: 77; our emphasis). 
Although no national diabetes indicators by ‘race’ and/or ethnicity are 
available,2 Mexico has taken a leading role in genomic research, search-
ing for ‘a genomic haplotype commonly found in Mexican and other Latin 
American mestizo populations and linked to indigenous genetic ancestry’ 
(Saldaña-Tejeda and Wade 2018: 2733; our emphasis).
This scientific endeavour has spurred public interest and wide-
spread media coverage, particularly after the foundation of the Instituto 
Nacional de Medicina Genómica (INMEGEN) in 2004 and the start of 
the Mexican Populations Genomic Diversity Project in 2005. In 2008, sci-
entists at the National Autonomous University of Mexico (UNAM) inau-
gurated the Genoteca Indígena, a project that aims to form a DNA bank 
from Mexican native populations. The objective is to know more about 
frequent diseases in Mexico, particularly diabetes, ‘from their origin’ (El 
Informador 2012). The investigation aims to detect the genetic poly-
morphisms associated with diabetes, which are said to be more frequent 
among indigenous peoples and, consequently, in Mexicans, depicted as a 
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mestizo population with a high percentage of indigenous genetic ances-
try (El Informador 2012).
Interviews and reports on the Genoteca Indígena released in 
Mexican media indicate that researchers give credit to James Neel’s 
thrifty gene hypothesis,3 although it remains unexplained in what ways 
Mexican indigenous peoples might have had a more nomadic life in 
the past than other populations. The biochemist leading the Genoteca 
Indígena project argues: ‘In the past, more than 6,000 years ago, when 
communities were nomadic, Mexican genetics allowed [Mexicans] to 
survive. This genetic make-up is today fattening them and making sugars 
harmful’ (Menjívar Iraheta 2009).
Even though Neel’s thrifty genotype is still an unproven hypothesis, 
its explanatory power has been astonishingly great (Fee 2006: 2990), as 
it provides an appealing answer to the high prevalence of diabetes and 
obesity among disparate ethnic groups, from the Pima of Arizona and the 
Oji-Cree of Ontario (Hegele et al. 1999) to Samoans (Minster et al. 2016) 
and Mexicans. Montoya (2011) underscores the fact that Neel’s hypoth-
esis remains elusive in at least two ways: the hypothesis rests upon dis-
putable assertions about feast and famine cycles among populations, 
and the population groups deemed diabetes-prone are not biological but 
social groups (2011: 48). Thus, both minority groups and large national 
populations (but ones with strong links with indigeneity) end up lumped 
together because they share genetic ‘ancestry’. In this regard, Ferreira 
and Lang ask: ‘How can a genetic cause be applied across the borders of 
300 million people divided into thousands of ethnic groups, living across 
the planet under strikingly different circumstances? What do these peo-
ple have in common? Their genes?’ (2006: 12).
Montoya (2011) suggests that the targeting of certain bodies as suit-
able DNA donors for research is made possible by the colonial practices 
that differentiated those bodies from the dominant ones in the first place, 
and confined them into poor neighbourhoods, plagued by poverty, neglect 
and therefore an excessive burden of disease. In the case of Mexico, it 
becomes clear that the reasoning by which (a) Mexicans are mestizos, (b) 
their indigenous genetic component is troublesome and (c) contemporary 
indigenous people should be targeted for DNA sampling is the direct result 
of Mexico’s (post-)colonial history, which created the entire concept of the 
indio (Bonfil Batalla 1972), used it to place indios (‘Indians’) at the bottom 
of society, and pushed them into regions of refuge (Aguirre Beltrán 1967).
As several scholars have argued, mestizaje heralded ‘the mixing of 
races rather than the separation of them, but without questioning the 
privilege of whiteness’ (Saldívar 2014: 94). The proposition ‘the whiter, 
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the better’ has structured Mexican racism, which works through ‘distrib-
uted intensities’ (Moreno Figueroa 2010) of white capital. The proposi-
tion ‘the whiter, the less predisposed to diabetes’, which seems implicit in 
the current scientific search for ancestral genetic backgrounds, sounds 
like the contemporary rendering of the Mexican mestizaje ideology. 
Indeed, the genomic enterprise – albeit not purposefully – articulates and 
is infused with racialised meanings that reflect cultural understandings 
of nationhood and alterity. As Wade et al. have pointed out:
Racialized categories are implied in the use of concepts of genetic 
ancestry – usually talked of in terms of African, European, and 
Amerindian components. For the geneticists, genetic ancestry 
(understood as very specific sets of genetic markers) is distinct 
from race (which they understood as a set of coherent biological- 
bodily types). But the constant reference to African, European, and 
Amerindian ancestries evokes familiar racial meanings.
(Wade et al. 2014: 497–8)
The Genoteca Indígena substantiates the idea of Mexicans as mestizos 
with a double genetic inheritance (the black component is largely over-
looked) and of native peoples as the authentic, ‘original’ key to Mexican 
biology. Consistent with this perspective, Mexican media explain the 
Genoteca Indígena project in the following way: ‘Indigenous genes: solu-
tion to diabetes’ (Ocampo 2013). The article details how:
Specialists agree that apart from promoting dietary and hygienic 
measures in the population, the only way to know the origin, com-
plications and therapeutic management of diabetes, and to develop 
diagnostic, prognostic and control methodologies, is to identify its 
hereditary components.
(Ocampo 2013; our emphasis)
In order to identify those hereditary components, researchers extract 
DNA from indigenous groups, the more ‘isolated’ the better. The logic is 
that isolated groups, being genetically more homogeneous, make for a 
good case study. One study on diabetes susceptibility, for example, found 
an association of genetic polymorphisms with the development of type 
2 diabetes in Mayas (Lara-Riegos et al. 2015). Researchers selected par-
ticipants who ‘confirmed a Maya origin, with parents and grandparents 
born in the same communities, speak their native language and preserve 
traditional folks’ (Lara-Riegos et al. 2015: 69).
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It is interesting to note that cultural and ethnic qualities were used 
as indicators of genetic ancestry. The choice of taking DNA from this eth-
nic group was justified on the grounds that Mayas are said to have little 
contribution of continental ancestry (Silva-Zolezzi et al. 2009, cited in 
Lara-Riegos et al. 2015: 69) and that the region they live in presents a 
high prevalence of diabetes. The blood samples were later genotyped 
to confirm Amerindian ancestry. The search for ‘isolated’ groups recalls 
ideas of ‘purity’, which anthropological and ethno-historical scholarship 
has often demonstrated to be at best imprecise and, at worst, pernicious 
(Kuper 1988). Thus the isolation of the Mayas of south-east Mexico 
appears at odds with past and present history. The historical record, for 
example, demonstrates intense black–Maya relations in Yucatán (Lutz 
and Restall 2005: 189). Although mixing was much more common in 
urban than in rural areas, by the eighteenth century (often informal) mis-
cegenation had become commonplace in Yucatán, especially ‘between 
enslaved African men and native or mixed-race women and, to a lesser 
extent, between female slaves and Spaniards’ (Lutz and Restall 2005: 
193). Although the study mentions the importance of considering local 
environmental factors, lifestyles and modes of subsistence (Lara-Riegos 
et al. 2015: 73), virtually nothing is said about this region’s social history 
and the processes of adaptation to changing political and environmen-
tal circumstances. Indigeneity appears, once more, as a biocultural unity 
(with specific genetic and linguistic/cultural markers) but socially and 
historically decontextualised.
Questions remain about how these ethno-racial representations of 
morbidity and alterity are appropriated by dominant and non-dominant 
sectors of society, and how indigenous peoples themselves make sense of 
diabetes as the institutions of science scrutinise their bodies.
In her ethnographic experience with Oaxacans from Santa Maria 
Atzompa, Everett (2011) found that the genetic aetiological accounts 
circulating in Mexico had not made inroads at the household level and 
genetic susceptibility was not part of the explanatory models of peo-
ple with diabetes. A similar finding comes from Laura’s ethnographic 
research among an ethnic minority in southern Oaxaca. During her year 
of fieldwork, nobody ever mentioned genetic susceptibility as depend-
ing on their ethnic belonging. When they were asked why they thought 
they got diabetes, they usually referred to strong emotions related to 
stressful life circumstances. Diabetes narratives revealed stories of 
poverty, unemployment, classism and physical and emotional abuse, 
phenomena that thrive in contexts where structural violence silently 
permeates social relations.
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Cristina, a woman in her fifties, had been diagnosed with diabetes 
18 years earlier. One year before Laura met her, she had started expe-
riencing diabetes complications and had had a toe amputated. When 
asked why she got diabetes, she said: ‘I got diabetes from a susto [fright], 
a coraje [anger] I had when I was young. My father was a prominent 
political figure and they killed him. I was only 25, the oldest among my 
siblings and I had to take care of them. That’s how I got diabetes.’ Cristina 
explained that her father’s killing hit her hard and that from that moment 
her life had been punctuated by several illness episodes. Moreover, dia-
betes affected her financially as she resorted to private medical doctors 
and expensive medications.
Pancho, a teacher living with diabetes for more than 15 years, was 
emaciated, unable to stand and on dialysis when Laura met him. He 
explained that his diabetes was due to a terrible susto he had in Mexico 
City when he took part in a street protest with his fellow teachers: ‘I was 
part of the struggle of the teachers’ union and during the protest we were 
attacked by riot policemen. They trampled on my compañeros and when 
I saw them falling I got terribly scared.’ He reacted so strongly to the vio-
lence he witnessed at the hands of the Mexican police, he said, that his 
blood turned sweet.
When research participants were asked about the great numbers of 
diabetics in their community, they talked about environmental and die-
tary change, culture loss and social disruption (Montesi 2017). Of the 38 
people in Laura’s sample, only four, all males (between 39 and 52 years 
of age), literate and with a relatively high socio-economic position (two 
had been in the past high-ranking officials in the municipality, one was 
a teacher and one co-owned a pharmacy) mentioned heredity as a possi-
ble causative factor. In these cases, genetics was related to family history, 
not to ethnic belonging. When she purposefully inquired about genetic 
susceptibility to diabetes, people denied such a predisposition, as the 
words of Anita, 55 years old and diagnosed with diabetes 18 years ear-
lier, demonstrate: ‘I don’t think it’s a matter of race because at the time 
of my grandmother and of my great-grandparents nobody had diabetes. 
Today everyone has diabetes, including the young.’ Most of the people 
with diabetes Laura worked with were first-generation diabetics, with 
vivid memories of healthy parents.
Aetiological accounts may change in the future as people with 
diabetes begin to have memories of disease in their own families and 
genetic explanations become more commonplace. Research into how 
younger generations understand diabetes aetiology and ethno-racial 
health outcomes is critical and urgent. As our opening anecdote with 
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the tourist guide shows, the Mexican susceptibility hypothesis is already 
being appropriated by urban people with greater access to media. 
Moreover, the genetic link of Mexicans (and ‘Latinos’ or ‘Hispanos’ more 
broadly) to diabetes has also found coverage in the US, strengthening 
racist attitudes towards Mexicans, as this comment in a racist website 
demonstrates:
I have commented several times here re. the high cost of diabetes to 
a society. Diabetics’ healthcare costs 2½ times the amount of non- 
diabetic healthcare. Diabetes is the cause of most blindness, ampu-
tations, kidney dialysis, & have 4x the chance of heart attack and 
stroke. A few years ago the New York Times had a week-long series of 
articles re. Latinos’ high rate of the disease. NYT claimed that 50% of 
them have it or will develop it! And they brought up the issue of their 
diets, and lack of exercise. I also heard top US health officials express 
their concern over the coming diabetes epidemic as we become a more 
Hispanic nation – and where the $$$$$$$$ is going to come from?
(SentryattheGate, comment on American Renaissance website, 
our emphasis)
In the current climate of white supremacism and rising numbers of hate 
crimes, it becomes imperative to look at the potentially stigmatising 
effects that racialising scientific narratives have on ethnic minorities.
Ethno-racial transplant medicine in the UK
Worldwide, increasing numbers of patients are affected by chronic kid-
ney disease (CKD) and end-stage renal disease (ESRD), and are putting 
a substantial burden on global healthcare resources. This is due to the 
growing numbers of elderly people and the global pandemic of type 2 
diabetes. In the UK, the annual incidence of ESRD has doubled over the 
past two decades to reach about 100 new patients per million of pop-
ulation (El Nahas and Bello 2005); this figure is expected to rise at an 
annual rate of 5–8 per cent (Lysaght 2002). ‘Racial factors’ have been 
described as playing a role in the susceptibility to CKD, as shown by the 
high prevalence of CKD related to hypertension, diabetes or both among 
BAME (black, Asian and minority ethnic) individuals in the UK (El Nahas 
and Bello 2005).
The National Institute for Health and Care Excellence (NICE) 
guidelines have identified higher-risk groups for diabetes, such as those 
aged 25–39 and of South Asian, Chinese, African-Caribbean or black 
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African descent (NICE 2017). In a research review from 2002, the UK’s 
Department of Health and the Medical Research Council attempted to 
address the rise of diabetes cases in minority communities, suggesting 
the implementation of innovative lifestyle changes, such as, for instance, 
working with Indian restaurants to provide low-fat alternatives on their 
menus (Department of Health 2002). Embedded in this health strategy 
lay the assumption that there was something ‘faulty’ within the minori-
ties’ diets which required a fix, reinforcing simplistic notions of minority 
culture and/or identity. This has also been promoted through the work of 
national network organisations such as Diabetes UK (Keval 2016).
Minority communities have been represented over the years as 
being at higher risk of getting diabetes and hence of experiencing related 
complications, such as kidney failure. The NHS website on organ dona-
tions and ethnicity states that patients from BAME communities are 
more likely to need an organ transplant than the rest of the population as 
they are more susceptible to illnesses such as diabetes and hypertension, 
which may result in organ failure and the need for a transplant. ESRD or 
chronic renal failure is permanent kidney failure (Gordon 2001; Sehgal 
1999) and is treated by one of three forms of renal replacement ther-
apy: haemodialysis (mainly done in hospitals), peritoneal dialysis (done 
usually at home) and kidney transplantation (Gordon 2001). Dialysis is 
the clinical purification of blood and thus it is a substitute for the normal 
function of the kidney. Dialysis is generally considered more expensive 
than kidney transplantation (Laupacis et al. 1996; Yen et al. 2004). In 
the foreword to a report on the Transplant Summit of 2006, the All-Party 
Parliamentary Kidney Group in the UK states that: ‘Transplantation is 
better for the patient. Furthermore, transplantation is cheaper than dial-
ysis. Increasing transplantation rates would therefore be an all-round 
win’ (All-Party Parliamentary Kidney Group 2006: 3).
This demonstrates how transplantation is depicted by modern bio-
medicine as the optimum treatment for end-of-stage kidney failure and as 
the cheapest option for healthcare systems. This solution to renal failure is 
represented as the best option not only for patients in terms of their qual-
ity of life but also for the rest of society in terms of expenditure on health-
care. However, despite this call for increasing the number of transplants, 
there is a shortage of organs, from living or cadaveric donors, across dif-
ferent countries. The 2006 Transplant Summit report also mentions that 
the UK currently has one of the lowest donation and transplantation rates 
amongst European countries. They continue by saying that this is con-
sidered to be partly because of differences in health service capacity and 
structure: for instance, the report cites Spain as an example, describing 
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it as having almost three times as many intensive care unit beds (from 
where donor organs are often retrieved) compared to the UK. In addition, 
the report lists ‘procedural and attitudinal short-comings’ as possible rea-
sons for the low rate of donations. The text continues by adding that:
Innovative solutions must be found to maximise the opportunities 
for donation within the UK so that we can bridge the gap between 
accelerating demand and the declining supply of suitable organs 
available for transplantation. A national campaign should be 
launched to encourage potential donors to join the organ donor 
register. This should make clear to potential donors what the conse-
quence of low donation rates are; not only for those individuals in 
need of an organ, but for the NHS as a whole.
(All-Party Parliamentary Kidney Group 2006: 7)
As a consequence, a public campaign to increase donations in the UK has 
been developed in the last decade. In the case of kidney transplantation, 
the campaign aims particularly to raise the number of living donations. It 
is common to find news aimed at increasing donations in the media. For 
instance, on 20 December 2016, the London Evening Standard published 
an article titled ‘Metropolitan police officer gives Christmas gift of life to 
sister by donating a kidney’. Interestingly, this is the story of two white 
siblings. The transplantation happened in a hospital in affluent Hamp-
stead (north London). The article ends with a comment by one of the 
consultants, saying, ‘If you know someone who needs an organ I would 
urge you to think about being a donor’. Readers then are redirected to the 
NHS website for further information.
Similarly, the charity Give a Kidney promotes non-directed (also 
known as altruistic) donation in the UK. More than 100 people donated 
in this way in the UK in both 2013/14 and 2014/15, and the numbers 
are expected to keep on track at more than 100 per year. Research on 
non-directed living kidney donations has shown that the anonymity of 
the donor and recipient appears to be seen as a benefit, freeing recipients 
from the obligations of the gift (Bailey et al. 2016).
However, medical anthropology research in Spain (Sánchez Hövel 
2014) has shown that public campaigns describe living donations as 
‘altruistic’ and ‘supportive/caring’, not taking into consideration the 
long-term holistic wellbeing of living donors and the regret of having 
donated a kidney on the part of living donors when their health deteri-
orates later in life. Further research is therefore needed to establish the 
long-term consequences of living donations for living donors.
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Undoubtedly, linking donation with gift-giving, altruism and 
self-sacrifice creates a ‘medical duty obligating both individuals and col-
lectivities’ (Kierans and Cooper 2013: 222) to act as donors. Research has 
shown that possible organ donors have different degrees of duty accord-
ing to the racial and/or ethnic categories they are thought to belong to 
(Avera 2009; Gordon 2002; Kierans and Cooper 2011). This classifica-
tory system is based on the assumption that some genetically inherited 
human leukocyte antigen (HLA) types as well as blood groups appear in 
certain ‘ethnic’ populations more commonly than others, meaning that 
patients may be more likely to find a transplant match with someone in 
the same ‘ethnic’ group (Avera 2009). Therefore, individuals and collec-
tivities thought to belong to certain ethnic or racial categories receive 
greater attention in terms of health campaigns aimed at increasing organ 
donation. This is the case of ethnic minorities in the UK, which are often 
urged to discuss organ donation (Siddique and Morris 2016).
For instance, in September 2017 the NHS had a specific website 
on organ donations and ethnicity that described BAME groups as ‘more 
likely to develop medical conditions that need blood, organs or tissue 
donations’. The website also mentioned that ‘people needing bone mar-
row are more likely to find a match with someone with a similar ethnic 
background’, crudely implying that genetics equates to ‘ethnicity’ and 
‘race’. This has slightly changed today, with ‘More donors from black, 
Asian and minority ethnic groups are urgently needed to address an 
increase in patients from the same communities dying whilst waiting for 
an organ transplant’.
As highlighted by previous medical anthropological research 
(Gordon 2002; Kierans and Cooper 2011), biological differences have 
been combined with race and ethnicity in this context, emphasising 
the largely arbitrary character of racial categorisations based on shared 
characteristics, such as, for example, skin colour (‘black’, ‘white’) or geo-
graphic location (‘Asian’). Moreover, ‘white’ HLA types are constructed as 
the standard against ‘rare’ ‘black’ HLA types, failing to account for racial 
mixing and mixed heritage (Kierans and Cooper 2011).
There is also the failure to acknowledge that developments in 
immunosuppressants make HLA (mis)matches increasingly irrelevant 
(Gordon 2002: 136). Cohen (2001) writes about how transplantation 
rapidly went global with the development, production and marketing of 
the immunosuppressant drug cyclosporine by the Swiss pharmaceutical 
corporation Sandoz. This made transplants possible from a far larger 
group of potential organ donors than before, profoundly affecting the 
harvesting of organs and transforming the productivity of transplant 
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clinics and their organ-donation targets. Research on pharmaceuticals 
shows how the macro level of the pharmaceutical industry and health-
care systems and the micro level of doctor–patient relations are inter-
connected (Britten 2008), affecting the expansion of pharmaceutical 
markets (Busfield 2010) and providing a quick and easy solution to the 
complex issues emerging when facing inequalities in access to transplan-
tation and transplant listing. Kierans and Cooper write that:
In its attempts to accommodate ‘rare’ HLA types, transplant med-
icine has fallen back on the same classificatory schemas that were 
implicated in the creation of the inequalities that recent policy 
shifts were intended to address – schemas that are based, primarily, 
on the assumption of a ‘natural’ basis for cultural differences.
(Kierans and Cooper 2011: 13)
Therefore, ‘ethnicity’ and ‘race’ become biopolitical constructions in trans-
plant medicine in the UK; these are often used to contrast the behaviour of 
ethnic minorities when it comes to donations in comparison to that of the 
‘white population’, implying a higher moral stance for the latter. During 
an interview4 in a renal unit in the UK, an Asian patient – we will call him 
Sadiq – in his forties told Melania:
They [healthcare professionals] said to me that a lot of Asian peo-
ple don’t donate organs. My mum went through it and one of her 
kidneys was only 30 per cent efficient so they said no because she 
obviously was living on one; and my wife was not compatible and 
then after that I told the rest of the family not to go for it because I 
didn’t want that responsibility. If it can happen to me it can happen 
to anybody in the family so I’ve just said I’d rather wait the time and 
wait for a donated dead one. […] Obviously, I got my brother and 
my sister, both of them went and had the tests done. I told them to go 
and have the tests done to make sure they don’t have any possibility 
of kidney problems so that they are clear. I didn’t want to take a kid-
ney from any of those just in case. […] We spoke to a few people and 
again a few of my cousins came forward and said they would donate, 
but then again, the mental state I was in at the time. I refused to take 
it. […] I mean my cousin was only 20 at the time he offered as well; 
he was very fit, but I just said no. I’d rather wait it out and take it 
from someone that has already died rather than taking it form some-
one that is living; and if they get any complication it’s just mentally 
you wouldn’t … you would feel responsible for that.
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The words of Sadiq mirror the attitudes and feelings of other renal 
patients Melania interviewed. Despite the difficulties of living on dial-
ysis and their daily suffering and pain – which Yannis, a Greek man in 
his fifties, described as a form of disability – patients find it extremely 
difficult to follow healthcare professionals’ advice to ask family members 
if they can act as living donors. This was also common among those who 
identified themselves as ‘white’; of the 53 people in the sample, many 
noted that they would feel ‘guilty’ and ‘to blame’ if the donor became sick 
later in life, following the donation. ‘I wouldn’t want anyone to carry that 
burden, you know’, commented Scott, a 69-year-old white British man.
Another important point is the fact that patients like Sadiq internal-
ise what healthcare professionals communicate to them regarding eth-
nic minorities and donations; this certainly has important repercussions 
in terms of self-identity as well as in terms of perceptions of their own 
communities. As Nazroo et al. (2007) have shown, treating categories – 
such as Caribbean, black and South Asian – as universal needs to be prob-
lematised. This challenges the ideology of transplant medicine in the 
UK, which identifies people from different continents as the same only 
because they are defined as ethnic minorities in the UK. Moreover, within 
the same ethnic groups there are many differences, and mixed heritage in 
an increasingly globalised world is not considered. For instance, in terms 
of vulnerability to cardiovascular disease, there are similarities between 
white British and South Asian British people when talking about their 
health experiences (Lambert and Sevak 1996). This leads to the conclu-
sion that using ‘race’ or ‘ethnicity’ to explain disease in a specific group is 
not robust enough.
Minority groups are constructed as dangerous to themselves and in 
opposition to the white majority; the ‘problematisation’ of minority health 
generates binary states of normal/pathological trajectories, with the lat-
ter associated with minority groups in the NHS in Britain (Keval 2016). As 
the UK government has, decade after decade, attempted to ‘manage race 
relations’ (Craig et al. 2012), there has been a corresponding effect on 
concepts of health and health services, with the notion of taking respon-
sibility for one’s own health becoming a prime focus for governments 
(Keval 2016) – for instance, through encouraging lifestyle changes.5
Therefore, in this context, minority communities are not only rep-
resented as being at higher risk of becoming diabetic, showing an evi-
dent ethno-racialisation of the disease, but solutions to diabetes’ further 
complications, such as kidney transplantation, are also constructed as 
ethno-racial issues, as minority individuals are represented as unwilling 
to act as donors.
 THE ETHNO-RACIAL BASIS OF CHRONIC DISEASES:  RETHINKING RACE 185
Hence, it is difficult to consider transplant medicine as a neutral 
biomedical technology (Ohnuki-Tierney et al. 1994), as it deeply affects 
and is also affected by cultural definitions of personhood and the dynam-
ics of social relations within families, communities and countries. It 
tests different boundaries (Kierans 2011: 1469) as bodies become arte-
facts for social and political control, through increasing fragmentation 
and commodification within the context of biomedicine and economics 
(Scheper-Hughes and Lock 1987). Through these medical and govern-
mental ethno-racial discourses, we can engage with constructions of 
sameness and alterity as transplant medicine provides a space to discuss 
what it means to be human, shedding light on the cultural and social con-
structions of the self and the other (Sharp 1995; Douglas 2003, 2004).
Conclusions
The re-enchantment of scientists and lay people with genetic aetiologies 
and solutions to health problems is a social phenomenon that deserves 
full attention. It is important to recognise, though, that this is often an 
ambivalent re-enchantment (Bliss 2012). The cases of Mexico and the UK 
demonstrate the vitality of race and ethnicity as categories that shape bio-
medical and popular understandings of health and illness and, therefore, 
have an impact on how public health interventions are imagined. Trans-
plant medicine and genetic modification (although not currently avail-
able) stand out as techno-fixes that operate at the individual level and 
simultaneously suit private interests. This has the inevitable consequence 
of shifting responsibilities for illnesses and conditions from the structural 
to the individual, yet they are marked by race and ethnicity. In Mexico, 
which is one of the largest consumers of sodas, the Coca-Cola Foundation 
has developed an interest in the genetic causes of diabetes: it is financially 
contributing to the Genoteca Indígena (Facultad de Química 2007). The 
suspicion is that the biggest producer of sugary drinks in the world has 
an interest in blaming faulty genes for the obesity and diabetes epidemic.
Epidemiology maps diseases along lines of race/ethnicity, gender 
or social class, providing a picture of a population's state of health. Its 
results can be used either to reinforce existing social hierarchies through 
racialised discourses of genetic predisposition compounded by unhealthy 
lifestyles or to explore social inequalities. CE offers theoretical tools to 
read ethnic and racial differences in this latter light, as the result of social 
histories marked by oppressive relationships that have an enduring, 
intergenerational impact on local biologies.
186 CRIT ICAL MEDICAL ANTHROPOLOGY:  PERSPECTIVES IN AND FROM LATIN AMERICA
Breilh (2010) contends that the biological is always endowed with 
historicity; this means that physical, chemical and biological phenom-
ena, as well as phenotypes and genotypes, are historically conditioned 
and cannot be isolated, fractioned or studied separately from their struc-
turing social processes. Moreover, he adds, the connection between the 
biological and the social is not an extrinsic one but exists by virtue of 
subsumption (subsunción) (2010: 16). What are the implications of this 
theoretical standpoint?
A CE approach does not deny ethno-racial differences in disease pat-
terns but sees them as incarnate results of pathways of power. This leads 
to novel conceptualisations of ‘race’. For example, Guthman has explored 
non-genomic ways of thinking about ‘race’ and biology, suggesting that 
social constructions of race not only have material effects on social lives 
but can somatise ‘race’ (2014: 1156). Likewise, the concept of local biol-
ogies (Lock and Nguyen 2010) stresses the continuous, multi-level inter-
actions among bodies within their life webs (Kuzawa and Sweet 2009).
Another relevant point of CE is the shift of gaze from ‘health’ to 
‘life’. Its object of inquiry is life itself, conceptualised as the sustaining 
web where everything happens or ceases to happen. This means that 
no aspect of our biology can be understood without taking into con-
sideration its embeddedness in a complex ecology of mutually consti-
tutive inter-relationships. Breilh criticises monocausal and multicausal 
explanations of disease because they favour proximate determinants 
of health over society-level ones. This critical posture has a practical, 
applied and political implication: if health has an intrinsic ‘collective’ 
nature, solutions to health crises have to be collective, too. Under this 
light, genes cannot be faulty, lifestyles cannot be bad and solutions can 
be technical only as a temporal relief. CE offers cues on how to over-
come ‘the epidemiological notion of the social as an inductive construc-
tion from the individual’ (Breilh 2010: 17). A CE approach, therefore, 
does not analyse patterns of health and disease as the sum of individual 
risky behaviours or genetic make-ups but as the outcome of structures 
of power at work. It is social relations that empower or constrain peo-
ple in and beyond their biologies. So what can a CE approach tell us 
about the appalling prevalence and incidence rates at which indigenous 
peoples and ethnic minorities worldwide experience diabetes or renal 
failure?
Ethnographic work on indigenous peoples with diabetes shows 
that diabetes sufferers link their illness to wider circumstances involv-
ing family and community disruption as well as social and environmen-
tal violence. The study of the narratives of people with diabetes reveals 
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what a strong contribution ethnography can bring to health studies and 
why a mere account of lifestyles cannot be regarded as sufficient to stem 
diabetes. For instance, the seriousness with which anthropologists have 
approached and listened to life histories has led them to acknowledge 
the emotional dimension of experiences of vulnerability (see Jacobo and 
Orr, this volume), and the synergistic interactions between violence, suf-
fering and diabetes (see Weaver and Mendenhall 2014, for instance). 
Biomedical studies have proved that ‘chronic stressor exposure (such as 
living in poverty) has a health impact that goes beyond the supposedly 
bad behaviour of some people’ (Kelly and Ismail 2015: 457).
Similarly, research on renal failure and transplantation can illumi-
nate how ethno-racial difference and sameness are constructed, repre-
sented and internalised by different social actors. The communicative 
process is highly dependent on and structured by inequalities of power 
and resources; the organ shortage implies an assumption that organs go 
to waste if not donated, so every citizen should contribute to the trans-
plant enterprise (Lock and Nguyen 2010). Normative theorists, clinicians 
and policy makers likely expect that patients make treatment decisions 
that enhance their health (Gordon 2001). Patients, however, make deci-
sions according to non-normative factors, including their emotional and 
social notions about the repercussions of organ donation on a donor and 
on the patient’s relationship with the donor. There is therefore a need for 
a renewed focus on patients’ self-identity to explore how their treatment 
choices are embedded in the many relationships within which they are 
implicated.
The moral economy of transplantation has largely been boosted 
because of the global epidemic of chronic diseases such as renal failure, 
hypertension and diabetes. However, substantive research indicates that 
chronic diseases are themselves ‘pathologies of power’ (Farmer 2004) 
and symptoms of gender, class and ethno-racial inequalities that become 
embodied and are passed down from generation to generation. In order 
to break with this intergenerational cycle of violence, radical societal 
transformations are needed. CE recognises the practical and ultimately 
political nature of the scientific enterprise since ‘there is an interdepend-
ence between how we look to reality, how we think it and how we act in it’ 
(Breilh 2010: 8). CE offers ‘collective health’ as a theoretical, methodo-
logical and applied tool that focuses on group processes as they generate 
specific ways of living and dying. The ‘social’ is not an external variable 
useful to understand patterns of disease in individuals and groups, but 
the very condition that enables ‘patterns’ to occur (Breilh 2013: 20). 
Under this paradigm, biogenetic reductionism has no raison d’être and its 
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exclusion from epidemiology clears the way for alternative explorations 
of race and ethnicity, which include the biological down to the genes but 
address them through a longue durée approach that links embodiment 
with social history.
Notes
1. See for instance the case of legal and spatial exclusion of Chinese immigrants suffering from 
leprosy in the province of British Columbia, Canada, where racialised governance came into 
practice through health strategies of segregation and isolation (Mawani 2003:3–21).
2. In 2012 the Mexican Ministry of Health started to include data on ethnicity in its administrative 
and epidemiological records, based on linguistic criteria (the patient speaks or does not speak 
an indigenous language). However, no data are available based on ethnic self- adscription.
3. In 1962, Neel proposed that the diabetic genotype was a ‘thrifty’ genotype, ‘in the sense of 
being exceptionally efficient in the intake and/or utilization of food’ (1962: 354). The spread 
and increase of diabetes worldwide was explained by Neel as an effect of ‘civilisation’. Stripped 
down to its essentials, he suggested that ‘genes and combinations of genes which were at one 
time an asset’, especially in the feast-or-famine days of hunting and gathering cultures, had 
become a liability ‘in the face of environmental change’ (1962: 359).
4. This research was part of the ATTOM study, which was funded by a grant from the Programme 
Grants for Applied Research (PGfAR) funding stream, from the National Institute of Health 
Research (NIHR), United Kingdom (ref: RP-PG-0109-10116). This publication presents 
independent research. The views expressed in this publication are those of the authors and 
not necessarily those of the NHS, the NIHR or the Department of Health.
5. See Menéndez (1998) for further details on where the concept of lifestyle comes from and 
the disciplinary differences (between medical anthropology and biomedicine/public health) 
when analysing it.
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